phentolamine

(redirected from Phentolamine mesylate)
Also found in: Thesaurus, Medical.
Related to Phentolamine mesylate: Regitine

phen·tol·a·mine

 (fĕn-tŏl′ə-mēn′)
n.
An alpha-blocker, C17H19N3O, used especially in the diagnosis and treatment of pheochromocytoma.

phentolamine

(fɛnˈtɒləˌmiːn; fɛnˈtɒləˌmɪn)
n
(Pharmacology) pharmacol a drug that is used to dilate the blood vessels and to treat high blood pressure that is due to phaeochromocytoma and also to treat impotence
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.phentolamine - a virility drug (trade name Vasomax) to treat erectile dysfunction in men
anti-impotence drug, virility drug - drug to treat impotence attributable to erectile dysfunction
References in periodicals archive ?
This award recognises Hikmas efforts to alleviate the shortages of Thiotepa for Injection and Phentolamine Mesylate for Injection.
It contains Phentolamine Mesylate, a short acting alpha-adrenergic blocker which causes vasodilatation of the endothelial smooth muscle.
Phentolamine mesylate is a drug designed to reverse residual soft-tissue local anesthesia.
The injectable drugs identified so far include: baclofen, betamethasone, phentolamine mesylate /papaverine (Bimix 30:1), clonidine, estradiol, hydromorphone, fentanyl, methylprednisole acetate, morphine sulfate/bupivacaine, papaverine, papaverine / phentolamine mesylate /prostaglandin (Super Trimix), testosterone cypionate, and testosterone / estradiol.
Phentolamine mesylate may prevent or significantly reduce the degree of dermal necrosis and sloughing of tissue that may occur with infiltration of sympathomimetic agents (CIBA, 1985; Hill, 1991).
Food and Drug Administration ( FDA ) for its supplemental Abbreviated New Drug Application ( sANDA ) for phentolamine mesylate ( phentolamine ) for injection USP, 5mg/vial and is today launching this product in the US market.
1:51-56), and co-authored by three leading clinical investigators of new treatments for erectile dysfunction, provides an overview of laboratory and clinical data concerning phentolamine mesylate, a non-specific adrenergic receptor antagonist, and the active ingredient in Vasomax(R).
Nasdaq:ZONA)(PCX:ZNG) announced today that the Company has elected to start a mechanistic study of phentolamine mesylate induced brown fat proliferation in rats.
was suspended due to safety concerns resulting from Zonagen's two-year rat carcinogenicity study with phentolamine mesylate, the active ingredient in Vasomax(R).